Search results
Bill Ackman Wants Your Money. Should You Buy Pershing Square USA?
Barrons.com· 20 hours agoFEATURES - MAIN Advisor Take Key takeaways from the Barron’s Advisor editorial team High-profile...
Drugmaker Mallinckrodt files for second bankruptcy in US
Reuters via Yahoo News· 9 months agoDrugmaker Mallinckrodt on Monday filed for its second bankruptcy in three years in the United...
Novo Stock Surges Out Of A Buy Zone On Ozempic's Commanding Sales Beat
Investor's Business Daily· 4 months agoNovo Nordisk stock popped Wednesday after the Danish drugmaker's biggest moneymaker, a diabetes...
Stock Market Volatile After Powell Speech; These Economic Reports Are A Worry
Investor's Business Daily· 8 months agoIndexes were erratic after comments from Fed Chair Jerome Powell left investors unsure about rate...
Dow Jones Slips After Bullish Week; Nike Slumps Ahead Of Earnings; Watch These Health Care Stocks...
Investor's Business Daily· 2 years agoThe stock market held on to a good chunk of last week's gains in afternoon trading Monday. Top...
2 Breakout Growth Stocks to Buy for the Long Haul
Motley Fool· 1 year agoAs a result, it's never a bad idea to consider buying equities with strong forward momentum. Here are two healthcare stocks that have been breaking out...
Leading Health Stock With Rising Earnings Estimates Nears Buy Point
Investor's Business Daily· 2 years agoIBD's Rising Profits Estimates screen finds top-ranked stocks with brightening profit outlooks....
5 Dividend Kings That Yield More Than Vanguard's Top Value ETF
Motley Fool via Yahoo Finance· 2 months agoWhen it comes to exchange-traded funds (ETF) with a value focus, one of the go-to choices is the...
3 Fabulous Dividend Stocks to Buy in February
Motley Fool via Yahoo Finance· 4 months agoAny time is a good time to buy solid dividend stocks. But this month is a special time to do so for one simple reason: There's an extra day for investors...
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters via Yahoo News· 8 months ago(Reuters) -Sandoz shares dipped on their market debut on Wednesday after the generic and biosimilar...
